PYPD
PolyPid Ltd.
There isn't enough reported data to score PYPD yet.
PYPD Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
PYPD's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
PYPD PE Valuation
PYPD has no meaningful PE right now: it lost money over the past year.
PYPD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| -- | |
| Limited | |
| Low |
Analysts expect PYPD's losses to grow, with revenue declining. However, they disagree widely on these estimates.
PYPD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.48 | +$2.35 |
| Q1 2026 | -$1.91 | +$2.39 |
| Q4 2025 | -$2.26 | +$2.71 |
| Q3 2025 | -$2.98 | +$4.70 |
| Q2 2025 | -$3.83 | +$6.03 |
| Q1 2025 | -$4.30 | +$8.26 |
PYPD is still losing money, but far less than before: $1.48 per share over the past year, against $12.56 at its worst in early 2024.
PYPD Quarterly Revenue
PYPD's revenue is shrinking: $0 last quarter.
PYPD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2023 | $0 | $0 |
| Q3 2023 | $0 | $0 |
| Q4 2022 | $0 | $0 |
| Q4 2021 | $0 | $0 |
| Q4 2020 | $0 | +$12.6M |
PYPD's free cash flow was $0 over the past year, against $0 the year before.
PYPD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +713K shares |
| 1 year | +76% | +9.8M shares |
| 3 years | +1430% | +21.2M shares |
PYPD has 23M diluted shares, up 76% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2023 | — |
| Q3 2023 | — |
PYPD hasn't bought back shares in the past year.
PYPD Net Leverage
PYPD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PYPD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.6 | Neutral |
| Stochastic | 83.4 | Overbought |
PYPD's weekly RSI is 69 (neutral) and its Stochastic is 83 (overbought).
PYPD PE vs Healthcare Sector
| Metric | PYPD | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
PYPD has no meaningful PE right now: it lost money over the past year.
PYPD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.42 | 18% above |
| 20 week MA | $5.13 | 25% above |
| 50 week MA | $4.70 | 36% above |
| 100 week MA | $3.95 | 62% above |
| 200 week MA | $5.85 | 9.4% above |
PYPD has climbed back above all five of its weekly moving averages, and it's now 9.4% above its 200-week average.
PYPD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $570.0 | $301.8 | -47% |
| 2021 | $301.8 | $172.5 | -43% |
| 2022 | $172.5 | $21.7 | -87% |
| 2023 | $21.7 | $3.80 | -82% |
| 2024 | $3.80 | $2.89 | -24% |
| 2025 | $2.89 | $4.07 | +41% |
| 2026 YTD | $4.07 | $6.40 | +57% |
PYPD is up 57% so far in 2026, after finishing lower in five of the previous six years.